Fully automated solution for SARS-CoV-2
NGS-based testing data analysis
Cloud-based solution designed by Flomics
Our world is dealing with a global pandemic that threatens life as we know it. The rapidly spreading coronavirus SARS-CoV-2 is a major public health emergency. Worldwide, scientists and healthcare providers are working together to provide information and solutions to fight this disease. As part of this healthcare community, Flomics is actively monitoring and contributing to the latest research findings, especially in the Next Generation Sequencing (NGS) field.
Flomics has joined forces with international biotech partners, specialized in NGS tests, to develop a cloud-based solution for COVID19 detection and research. Whether you work in a hospital, clinic or research laboratory, with a few clicks you can transform your raw data into interpretable clinical information that will help manage this pandemic, without the need for bioinformatics expertise.
Flomics team offers end-to-end support from experimental setup selection to customized data reporting.
Automated COVID-19 next generation sequencing data analysis
Primer removal (for amplicon data)
Viral load calculation
Variant calling and annotation
A pipeline adapted to your needs:
- Metagenomic, Amplicon-seq
- Compatible with all sequencing platforms: Illumina, MGI, …
- Always up-to-date with the latest SARS-CoV-2 genome databases
Ready for data from:
Any targeted SARS-CoV-2 Amplicon sequencing kit
Your usual Total RNA kit for shotgun metagenomics
Get in touch and we can assist you in the optimal experimental setup
Reproducibility is our top priority:
- OS-independent (it runs on the cloud)
- Nextflow based pipeline
- Docker integration
Inquire for more info and account creation: